Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Peptide array" patented technology

Flagellin epitope peptides and uses thereof

PendingUS20260140112A1Disease diagnosisBacteria peptidesEpitopeFlagellin
Provided herein is a peptide array comprising a plurality of flagellin peptides corresponding to highly conserved peptide regions. For example, the peptide array comprises a plurality of Lachnospiraceae flagellin peptides, which can be selected from a hinge region of Lachnospiraceae flagellin. Also provided is antibody of fragment thereof that binds to one or more of the plurality of the flagellin peptides in the peptide array. The peptide array and antibody are useful in determining an immunosignature from a biological sample from a subject. The immunosignature is useful in diagnosis of an immune-mediated disease, in monitoring progression of an immune-mediated disease, in identifying subjects susceptible to certain treatments, and in monitoring treatment response.
Owner:THE UAB RESEARCH FOUNDATION INC

Protein-based biomarkers and related aspects for differentiating LYME disease from other non-LYME febrile diseases

PCT designated stageWO2026050338A1Peptide librariesMedical data miningDiseaseBinding pattern
Provided herein is a method of generating a binding pattern from a sample obtained from a subject. In some embodiments, the method includes detecting binding of antibodies from the sample to an array of peptides that each comprise at least subsequences of B. burgdorferi protein sequences listed in SEQ ID NOS: 1-45 to produce a detected binding data set, and identifying one or more binding patterns in the detected binding data set. In some embodiments, the method includes classifying the binding pattern as indicative of the subject having Lyme disease, as indicative of the subject not having Lyme disease, or as indicative of the subject having a non-Lyme febrile disease. Provided also herein are other methods and related reaction mixtures, compositions, kits, devices, systems, and computer readable media.
Owner:THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA

Substrates, peptide arrays, and methods

Disclosed herein are formulations, substrates, and arrays. Also disclosed herein are methods for manufacturing and using the formulations, substrates, and arrays. Also disclosed are methods for identifying peptide sequences useful for diagnosis and treatment of disorders, and methods for using the peptide sequences for diagnosis and treatment of disorders, e.g., celiac disorder. In certain embodiments, substrates and arrays comprise a porous layer for synthesis and attachment of polymers or biomolecules.
Owner:VIBRANT HLDG

tTG-DGP biomarkers for monitoring celiac disease

The present disclosure relates generally to biomarkers and peptide arrays, and, more particularly, to a method of using a peptide array to identify biomarkers for an autoimmune disease such as, e.g., Celiac disease. Furthermore, a set of novel biomarkers for Celiac disease, having high sensitivity and specificity, are disclosed in addition to method of treatment using the novel biomarkers.
Owner:VIBRANT HLDG +1

Peptide microarrays and novel biomarkers for celiac disease

The present disclosure relates generally to biomarkers and peptide arrays, and, more particularly, to a method of using a peptide array to identify biomarkers for an autoimmune disease such as, e.g., celiac disease. Furthermore, a set of novel biomarkers for celiac disease, having high sensitivity and specificity, are disclosed in addition to method of treatment using the novel biomarkers.
Owner:VIBRANT HLDG